Citations

Showing 10 of 108119 citations.

Early Descriptions of Family Caregivers' Experiences With Unexpected Lucidity
Bangerter, Lauren R. , Biggar, Virginia , Finnie, Dawn, Frangiosa, Theresa, Kim, Kyungmin , Griffin, Joan M. , Finnie, Dawn M., Gaugler, Joseph E. , Lapid, Maria I.

Mayo Clinic

Innovation in Aging | December 17, 2021 | Volume: 5 | Issue: Supplement_1 | Pages: 47-47

10.1093/geroni/igab046.178 Get It

Abstract To develop an operational definition of and typologies for episodes of lucidity (EL), we conducted a cross-sectional study of former/current family caregivers from UsAgainstAlzheimer’s A_LIST (N = 538). More than 60% of caregivers (n = 294, 62%) reported witnessing EL with their care recipient over the course of their dementia. Most episodes happened in late stages of dementia (71%). Only 10% happened within 7 days before death. The majority of episodes (71%) lasted <30 minutes. About half the episodes were characterized by uncharacteristic speech and communication. Caregivers perceived these experiences positively (M = 4.10; range = 1–5), but also expressed desire to know why/when EL occurs and how to best respond to it. Data will be used to refine definitions and typologies, and then a prospective, demographically diverse survey will be administered to family caregivers to assess predictors of EL, linking EL to caregiver well-being and bereavement response.
COP Cells in States of Bone Anabolism and Abnormal Calcification/Ossification
Pignolo, Robert J.

Mayo Clinic

Innovation in Aging | December 17, 2021 | Volume: 5 | Issue: Supplement_1 | Pages: 45-45

10.1093/geroni/igab046.169 Get It

Abstract Circulating osteogenic progenitor (COP) cells are a population of cells in the peripheral blood with the capacity for bone formation, as well as broader differentiation into mesoderm-like cells in vitro. There are several pathologies of accelerated bone formation and physiological responses to injury in which COP cells have been theorized to play a role. These include fracture, vascular calcification, and subtypes of heterotopic ossification (HO). Overall, the available studies suggest COP cells are likely to be mobilized in response to fracture, home to the site of injury, undergo a maturation process, and contribute to the osteogenesis and angiogenesis required for fracture healing. HO is the pathological process of bone formation in nonskeletal tissue and can be acquired or hereditary. COP cells may seed sites of injury and inflammation that precede the formation of endochondral bone identified in both genetic and nongenetic forms of HO. Vascular calcification is a common occurrence in older adults and is strongly associated with poorer cardiovascular health outcomes. It appears that COP cells, particularly those expressing hematopoietic and vascular markers such as CD45 and CD34, contribute to the calcification and ossification of atherosclerotic plaques and aortic valves, and that they correlate to the severity of the calcification. Whether COP cells are attracted to sites of injury and inflammation and so are highly associated with fracture, vascular calcification/ossification and HO, or whether they underlie these processes at a more mechanistic level, remains to be more clearly demonstrated.
Studying APOE ɛ4 Allele Dose Effects with a Univariate Morphometry Biomarker
Wang, Gang, Initiative, for the Alzheimer’s Disease Neuroimaging, Zhou, Wenju, Kong, Deping, Qu, Zongshuai, Ba, Maowen, Hao, Jinguang, Yao, Tao, Dong, Qunxi, Su, Yi, Reiman, Eric M., Caselli, Richard J., Chen, Kewei, Wang, Yalin, Wang, Gang, Initiative, for the Alzheimer’s Disease Neuroimaging, Zhou, Wenju, Kong, Deping, Qu, Zongshuai, Ba, Maowen, Hao, Jinguang, Yao, Tao, Dong, Qunxi, Su, Yi, Reiman, Eric M., Caselli, Richard J., Chen, Kewei, Wang, Yalin

Mayo Clinic

Journal of Alzheimer's Disease | December 17, 2021 | Volume: 85 | Issue: 3 | Pages: 1233-1250

10.3233/jad-215149 | PMID 34924383 Get It

Background: A univariate neurodegeneration biomarker (UNB) based on MRI with strong statistical discrimination power would be highly desirable for studying hippocampal surface morphological changes associated with APOE ɛ4 genetic risk for AD in the cognitively unimpaired (CU) population. However, existing UNB work either fails to model large group variances or does not capture AD induced changes. Objective: We proposed a subspace decomposition method capable of exploiting a UNB to represent the hippocampal morphological changes related to the APOE ɛ4 dose effects among the longitudinal APOE ɛ4 homozygotes (HM, N = 30), heterozygotes (HT, N = 49) and non-carriers (NC, N = 61). Methods: Rank minimization mechanism combined with sparse constraint considering the local continuity of the hippocampal atrophy regions is used to extract group common structures. Based on the group common structures of amyloid-β (Aβ) positive AD patients and Aβ negative CU subjects, we identified the regions-of-interest (ROI), which reflect significant morphometry changes caused by the AD development. Then univariate morphometry index (UMI) is constructed from these ROIs. Results: The proposed UMI demonstrates a more substantial statistical discrimination power to distinguish the longitudinal groups with different APOE ɛ4 genotypes than the hippocampal volume measurements. And different APOE ɛ4 allele load affects the shrinkage rate of the hippocampus, i.e., HM genotype will cause the largest atrophy rate, followed by HT, and the smallest is NC. Conclusion: The UMIs may capture the APOE ɛ4 risk allele-induced brain morphometry abnormalities and reveal the dose effects of APOE ɛ4 on the hippocampal morphology in cognitively normal individuals.
Age-Dependent Changes in the Plasma and Brain Pharmacokinetics of Amyloid-β Peptides and Insulin
Zhou, Andrew L., Sharda, Nidhi, Sarma, Vidur , Ahlschwede, Kristen M. , Curran, Geoffry L., Poduslo, Joseph F., Lowe, Val J. , Kandimalla, Karunya K. , Kandimalla, Karunya K , Tang, Xiaojia , Kalari, Krishna R.

Mayo Clinic

Journal of Alzheimer's Disease | December 17, 2021 | Volume: 85 | Issue: 3 | Pages: 1031-1044

10.3233/jad-215128 | PMID 34924382 Get It

Background: Age is the most common risk factor for Alzheimer’s disease (AD), a neurodegenerative disorder characterized by the hallmarks of toxic amyloid-β (Aβ) plaques and hyperphosphorylated tau tangles. Moreover, sub-physiological brain insulin levels have emerged as a pathological manifestation of AD. Objective: Identify age-related changes in the plasma disposition and blood-brain barrier (BBB) trafficking of Aβ peptides and insulin in mice. Methods: Upon systemic injection of 125I-Aβ40, 125I-Aβ42, or 125I-insulin, the plasma pharmacokinetics and brain influx were assessed in wild-type (WT) or AD transgenic (APP/PS1) mice at various ages. Additionally, publicly available single-cell RNA-Seq data [GSE129788] was employed to investigate pathways regulating BBB transport in WT mice at different ages. Results: The brain influx of 125I-Aβ40, estimated as the permeability-surface area product, decreased with age, accompanied by an increase in plasma AUC. In contrast, the brain influx of 125I-Aβ42 increased with age, accompanied by a decrease in plasma AUC. The age-dependent changes observed in WT mice were accelerated in APP/PS1 mice. As seen with 125I-Aβ40, the brain influx of 125I-insulin decreased with age in WT mice, accompanied by an increase in plasma AUC. This finding was further supported by dynamic single-photon emission computed tomography (SPECT/CT) imaging studies. RAGE and PI3K/AKT signaling pathways at the BBB, which are implicated in Aβ and insulin transcytosis, respectively, were upregulated with age in WT mice, indicating BBB insulin resistance. Conclusion: Aging differentially affects the plasma pharmacokinetics and brain influx of Aβ isoforms and insulin in a manner that could potentially augment AD risk.
The Learning Curve for Radiofrequency Ablation of Benign Thyroid Nodules
Clark, Jennifer , Stan, Marius N.

Mayo Clinic

Clinical Thyroidology | December 17, 2021 | Volume: 33 | Issue: 12 | Pages: 529-531

10.1089/ct.2021;33.529-531 Get It

Iron Deficiency Is Associated with Maternal Hypothyroxinemia in the Third Trimester of Pregnancy
Albashaireh, Arwa , Maraka, Spyridoula

Mayo Clinic

Clinical Thyroidology | December 17, 2021 | Volume: 33 | Issue: 12 | Pages: 526-528

10.1089/ct.2021;33.526-528 Get It

Mapping a Strength-Oriented Approach to a Standardized Terminology: A Case Study
Gao, Grace , Austin, Robin , Kirk, Laura , Holland, Diane E. , Bruhjell, Candice, Monsen, Karen A. , Austin, Robin R

Mayo Clinic

Studies in Health Technology and Informatics | December 17, 2021 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.3233/shti210751 | PMID 34920552 Get It

As a new era of healthcare advocates a more valuable and intelligent approach to care management and delivery based on values and outcomes, shifts toward risk management to boost performance should be considered that encompass the capitalization of health assets or health strengths. To make full use of individuals’ or populations’ health assets, data capture and representation are needed. This paper uses a strengths-oriented case study mapped to an inter-disciplinary standardized terminology, the Omaha System, to illustrate and compare the conventional problem-based approach to care management with the strengths-oriented approach to care that demonstrates whole-person data capture of an individual’s health and health assets leveraged to promote health values and performance. The Omaha system provides a standardized framework to organize the concepts of all of health from a whole-person perspective for documentation to enable data analysis, interoperability, and health information exchange.
Transcriptomic analysis of Streptococcus agalactiae periprosthetic joint infection
Masters, Thao , Greenwood‐Quaintance, Kerryl E. , Johnson, Stephen , Pu, Meng , Patel, Robin , Cho, Hye-Kyung, Jeraldo, Patricio R , Patel, Robin , Cho, Hye-Kyung , Jeraldo, Patricio , Chia, Nicholas , Abdel, Matthew P.

Mayo Clinic

MicrobiologyOpen | December 17, 2021 | Volume: 10 | Issue: 6 | Pages: No page available

10.1002/mbo3.1256 | PMID 34964296 Get It

AbstractAlthough Streptococcus agalactiae periprosthetic joint infection (PJI) is not as prevalent as staphylococcal PJI, invasive S. agalactiae infection is not uncommon. Here, RNA‐seq was used to perform transcriptomic analysis of S. agalactiae PJI using fluid derived from sonication of explanted arthroplasties of subjects with S. agalactiae PJI, with results compared to those of S. agalactiae strain NEM316 grown in vitro. A total of 227 genes with outlier expression were found (164 upregulated and 63 downregulated) between PJI sonicate fluid and in vitro conditions. Functional enrichment analysis showed genes involved in mobilome and inorganic ion transport and metabolism to be most enriched. Genes involved in nickel, copper, and zinc transport, were upregulated. Among known virulence factors, cyl operon genes, encoding β‐hemolysin/cytolysin, were consistently highly expressed in PJI versus in vitro. The data presented provide insight into S. agalactiae PJI pathogenesis and may be a resource for identification of novel PJI therapeutics or vaccines against invasive S. agalactiae infections.
Durability of Response to Primary Chemoablation of Low-Grade Upper Tract Urothelial Carcinoma Using UGN-101, a Mitomycin-Containing Reverse Thermal Gel: OLYMPUS Trial Final Report
Matin, Surena F., Pierorazio, Phillip M., Kleinmann, Nir, Gore, John L., Shabsigh, Ahmad, Hu, Brian, Chamie, Karim, Godoy, Guilherme, Hubosky, Scott G., Rivera, Marcelino, O’Donnell, Michael, Quek, Marcus, Raman, Jay D., Knoedler, John J., Scherr, Douglas, Weight, Christopher, Weizer, Alon, Woods, Michael, Kaimakliotis, Hristos, Smith, Angela B., Linehan, Jennifer, Coleman, Jonathan, Humphreys, Mitchell R., Pak, Raymond, Lifshitz, David, Verni, Michael, Klein, Ifat, Konorty, Marina, Strauss-Ayali, Dalit, Hakim, Gil, Seltzer, Elyse, Schoenberg, Mark, Lerner, Seth P., O’Donnell, Michael A. , Pak, Raymond W. , O'Donnell, Michael A , Matin, Surena F., Pierorazio, Phillip M., Kleinmann, Nir, Gore, John L., Shabsigh, Ahmad, Hu, Brian, Chamie, Karim, Godoy, Guilherme, Hubosky, Scott G., Rivera, Marcelino, O’Donnell, Michael, Quek, Marcus, Raman, Jay D., Knoedler, John J., Scherr, Douglas, Weight, Christopher, Weizer, Alon, Woods, Michael, Kaimakliotis, Hristos, Smith, Angela B., Linehan, Jennifer, Coleman, Jonathan, Humphreys, Mitchell R., Pak, Ray , Lifshitz, David, Verni, Michael, Klein, Ifat, Konorty, Marina, Strauss-Ayali, Dalit, Hakim, Gil, Seltzer, Elyse, Schoenberg, Mark, Lerner, Seth P.

Mayo Clinic

Journal of Urology | December 17, 2021 | Volume: 207 | Issue: 4 | Pages: 779-788

10.1097/ju.0000000000002350 | PMID 34915741 Get It

Diabetes and pre‐diabetes in patients with heart failure and preserved ejection fraction
Jackson, Alice M. , Claggett, Brian , Gong, Jianjian , Lefkowitz, Martin, Maggioni, Aldo P. , Martínez, Felipe A. , Pieske, Burkert , Redfield, Margaret M. , Rizkala, Adel R. , Rouleau, Jean L. , Seferović, Petar , Veldhuisen, Dirk J. van , Yılmaz, Mehmet Birhan , Zannad, Faı̈ez , Køber, Lars , Petrie, Mark C. , Solomon, Scott D. , McMurray, John J.V. , McMurray, John J V , Maggioni, Aldo P , Petrie, Mark C , Køber, Lars , Rørth, Rasmus , Liu, Jiankang , Kristensen, Søren Lund , Anand, Inder S. , Cleland, John G.F. , Chopra, Vijay , Desai, Akshay S , Ge, Junbo , Lam, Carolyn S.P. , Packer, Milton , Pfeffer, Marc Alan , Tromp, Jasper , Zile, Michael R. , Jhund, Pardeep S. , Solomon, Scott David

Mayo Clinic

European Journal of Heart Failure | December 17, 2021 | Volume: 24 | Issue: 3 | Pages: 497-509

10.1002/ejhf.2403 | PMID 34918855 Get It

Aim There is an association between heart failure with preserved ejection fraction (HFpEF) and insulin resistance, but less is known about the diabetic continuum, and in particular about pre‐diabetes, in HFpEF. We examined characteristics and outcomes of participants with diabetes or pre‐diabetes in PARAGON‐HF. Methods and results Patients aged ≥50 years with left ventricular ejection fraction ≥45%, structural heart disease and elevated N‐terminal pro‐B‐type natriuretic peptide (NT‐proBNP) were eligible. Patients were classified according to glycated haemoglobin (HbA1c): (i) normal HbA1c, <6.0%; (ii) pre‐diabetes, 6.0%–6.4%; (iii) diabetes, ≥6.5% or history of diabetes. The primary outcome was a composite of cardiovascular (CV) death and total heart failure hospitalizations (HFH). Of 4796 patients, 50% had diabetes and 18% had pre‐diabetes. Compared to patients with normal HbA1c, patients with pre‐diabetes and diabetes more often were obese, had a history of myocardial infarction and had lower Kansas City Cardiomyopathy Questionnaire scores, while patients with diabetes had more clinical evidence of congestion, but similar NT‐proBNP concentrations. The risks of the primary composite outcome (rate ratio [RR] 1.59, 95% confidence interval [CI] 1.35–1.88), total HFH (RR 1.67, 95% CI 1.39–2.02) and CV death (hazard ratio [HR] 1.35, 95% CI 1.07–1.71) were higher among patients with diabetes, compared to those with normal HbA1c. Patients with pre‐diabetes had a higher risk (which was intermediate between that of patients with diabetes and those with normal HbA1c) of the primary outcome (HR 1.27, 95% CI 1.00–1.60) and HFH (HR 1.35, 95% CI 1.03–1.77), but not of CV death (HR 1.02, 95% CI 0.75–1.40). Patients with diabetes treated with insulin had worse outcomes than those not, and those with ‘lean diabetes’ had similar mortality rates to those with a higher body mass index, but lower rates of HFH. Conclusion Pre‐diabetes is common in patients with HFpEF and is associated with worse clinical status and greater risk of HFH. Clinical Trial Registration: ClinicalTrials.gov Identifier NCT01920711.